An observational study in Psoriasis, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Al-Azhar University · Observational
VEGF and Nailfold Changes in Psoriasis
Correlation Between Serum Vascular Endothelial Growth Factor (VEGF) Levels and Nailfold Capillaroscopic Changes in Psoriatic Patients
2,028 studies on the registry are indexed under Psoriasis; 275 are open to participants now.
This study's enrollment of 79 is below the median of 199 across 407 observational studies indexed under Psoriasis.
Browse Psoriasis studies →Al-Azhar University is the lead sponsor of 531 studies on the registry; 172 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with psoriasis attending the dermatology outpatient clinics at Al-Hussein and Sayyid Galal University Hospitals.
Inclusion Criteria:
Patients diagnosed with psoriasis. Attending the Dermatology Outpatient Clinics at Al-Hussein University Hospital and Sayyid Galal University Hospital between September 2025 and March 2026.
Exclusion Criteria:
Connective tissue diseases (e.g., systemic sclerosis, SLE). Diabetes mellitus or peripheral vascular disease. Smoking. Pregnancy. Recent use of vasodilators or beta-blockers. Manual workers with vibrating tools. -
Exclusion Criteria:
-
Patients diagnosed with psoriasis attending the Dermatology Outpatient Clinics at Al-Hussein University Hospital and Sayyid Galal University Hospital between September 2025 and March 2026.
Correlation of serum VEGF levels with nailfold capillaroscopy findings in psoriasis patients
Correlating serum VEGF levels (measured by ELISA) with clinical microvascular findings assessed by nailfold capillaroscopy in psoriasis patients, to determine whether nailfold capillaroscopy can be used as a clinical tool for assessing disease severity.
Time frame: At the time of patient enrollment and clinical assessment (between September 2025 and March 2026)
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2025 to primary completion in Mar 2026, 6 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.